Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Enable New Diagnostics for Pulmonary Microbes in People With CF (SEND-CF)

NCT07312734 is registered in ClinicalTrials.gov with Chris Goss as lead sponsor.

NCT NCT07312734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07312734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF (SEND-CF)
Lead sponsor
Chris Goss
Phase
Observational
Overall status
Recruiting
Start date
March 30, 2026
Completion date
August 1, 2027
Enrollment
300 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis (cf), new diagnostics